Showing 2091-2100 of 3223 results for "".
- CMS Releases Guidance for How Health Systems Can Restart Elective Procedureshttps://modernod.com/news/cms-releases-guidance-for-how-health-systems-can-restart-elective-procedures/2477620/As new cases COVID-19 begin to flatten or subside in certain areas, the Centers for Medicare & Medicaid Services (CMS) has released new guidance for how health systems can restart electi
- Alimera Sciences Pre-Announces Expected Topline Revenue for Q1 2020 and Provides COVID-19 Business Updatehttps://modernod.com/news/alimera-sciences-pre-announces-expected-topline-revenue-for-q1-2020-and-provides-covid-19-business-update/2477586/Alimera Sciences announced topline revenue guidance for the quarter ending March 31, 2020. Alimera expects to report consolidated net revenue for the first quarter of 2020 exceeding $14 million, which compares to $12.9 million in the first quarter of 2019. Additionally, the company strengthened i
- Aldeyra Therapeutics Announces Potential of ADX-629 to Treat COVID-19 Patientshttps://modernod.com/news/aldeyra-therapeutics-announces-potential-of-adx-629-to-treat-covid-19-patients/2477578/Aldeyra Therapeutics, which has several drug candidates for the treatment of ocular inflammatory diseases, plans to facilitate the clinical testing of its drug candidate ADX-629 in patients with COVID-19-associated respiratory compromise. The company has requested a pre-investigational new drug m
- Alcon Provides Update on COVID-19https://modernod.com/news/alcon-provides-update-on-covid-19/2477538/Alcon announced a series of updates stemming from the impact of COVID-19. Alcon has initiated business continuity plans designed to keep its associates and customers safe while continuing to deliver critical eye care needs for the global healthcare community. These plans include directing
- China Gives Green Light to Allergan’s Xen Registration for the Surgical Management of Refractory Glaucomahttps://modernod.com/news/china-gives-green-light-to-allergans-xen-registration-for-the-surgical-management-of-refractory-glaucoma/2477514/Allergan announced China’s National Medical Products Administration (NMPA) approved the registration of Allergan’s Xen Gel Stent on March 26, 2020 for the surgical management of patients with refractory glaucoma. Xen is th
- Allergan COVID-19 Response: Program Enhancementshttps://modernod.com/news/allergan-covid-19-response-program-enhancements/2477507/Allergan has announced several program enhancements designed to assist eye care professionals and patients during the COVID-19 pandemic. These include: Lowering copay savings card offerings for Restas
- The Allergan Foundation Donates $2 Million to Community Organizations on Front Line of COVID-19 Responsehttps://modernod.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/Allergan announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020. The 2020 donations support programs dedicated to the COVID-19 pandemic response, as well as initiatives supporting mental health, eye care, and breast
- Aldeyra to Screen Clinical-Stage Compounds for Activity in COVID-19 Infectionhttps://modernod.com/news/aldeyra-to-screen-clinical-stage-compounds-for-activity-in-covid-19-infection/2477461/Aldeyra Therapeutics announced that it will begin screening its library of novel reactive aldehyde species (RASP) inhibitors, including ADX-629 and reproxalap, for potential anti-inflammatory and antiviral activity in the treatment of COVID-19 infection. ADX-629 and reproxalap are structur
- American College of Surgeons Releases New Clinical Guidance Document For Elective Surgical Case Triage During COVID-19https://modernod.com/news/american-college-of-surgeons-releases-new-clinical-guidance-document-for-elective-surgical-case-triage-during-covid-19/2477456/To assist in surgical decision-making in curtailing cases, The American College of Surgeons (ACS) released “COVID-19: Elective Case Triage Guidelines for Surgical Care,” a new surgical triage document that was developed following expert review in several specialties and provides trust
- Many Drugs Already Approved by FDA May Have Promise Against COVID-19https://modernod.com/news/many-drugs-already-approved-by-fda-may-have-promise-against-covid-19/2477451/Two new studies each suggest that dozens of drugs already approved for use in the United States may prove effective against the new coronavirus, according to